TipRanks
Global Pharmatech Inc (GBLP)
OTHER OTC:GBLP
US Market
GBLP
Global Pharmatech
RESEARCH TOOLSreports

Global Pharmatech (GBLP) Income Statement

6 Followers

Global Pharmatech Income Statement

Last quarter (Q1 2026), Global Pharmatech's total revenue was $328.19K, an increase of 1165.48% from the same quarter last year. In Q1, Global Pharmatech's net income was $48.31K. See Global Pharmatech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 310.89K$ 66.38K$ 58.59K$ 0.00
Gross Profit
$ 34.66K$ 43.82K$ 29.40K$ 0.00
Operating Expenses
$ 102.47K$ 183.39K$ 51.20K$ 113.28K
Depreciation and Amortization
$ 7.21K$ 167.90K$ 228.49K$ 236.56K
EBITDA
$ -59.91K$ 29.76K$ 207.59K$ -113.28K
Operating Income
$ -67.81K$ -139.57K$ -21.80K$ -113.28K
Other Income/Expenses
$ 87.00$ 1.08K$ 796.00$ -35.00
Pretax Income
$ -67.73K$ -138.50K$ -21.00K$ -113.31K
Net Income
$ -67.73K$ -138.50K$ -21.00K$ -113.31K
Per Share Metrics
Basic EPS
$ >-0.01$ 0.00$ 0.00$ >-0.01
Diluted EPS
$ >-0.01$ 0.00$ 0.00$ >-0.01
Weighted Average Shares Outstanding
 405.21M 395.21M 282.85M 276.35M
Weighted Average Shares Outstanding (Diluted)
 405.21M 395.21M 282.85M 276.35M
Currency in USD

Global Pharmatech Earnings and Revenue History